These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1084 related items for PubMed ID: 18063917

  • 1. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
    Kluz J, Kopeć W, Jakobsche U, Prajs I, Adamiec R.
    Postepy Hig Med Dosw (Online); 2007 Dec 03; 61():725-35. PubMed ID: 18063917
    [Abstract] [Full Text] [Related]

  • 2. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
    Kluz J, Kopeć W, Jakobsche-Policht U, Adamiec R.
    Int Angiol; 2009 Jun 03; 28(3):192-201. PubMed ID: 19506538
    [Abstract] [Full Text] [Related]

  • 3. Upregulated expression and function of integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis.
    Takeuchi T, Amano K, Sekine H, Koide J, Abe T.
    J Clin Invest; 1993 Dec 03; 92(6):3008-16. PubMed ID: 8254055
    [Abstract] [Full Text] [Related]

  • 4. Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair.
    Elshal M, Abdelaziz A, Abbas A, Mahmoud K, Fathy H, El Mongy S, El-Basyuoni S, Ahmed H, McCoy P.
    Nephrol Dial Transplant; 2009 May 03; 24(5):1495-9. PubMed ID: 19039027
    [Abstract] [Full Text] [Related]

  • 5. CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity.
    Su CC, Shau WY, Wang CR, Chuang CY, Chen CY.
    Lupus; 1997 May 03; 6(5):449-54. PubMed ID: 9229364
    [Abstract] [Full Text] [Related]

  • 6. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL, Mason JC, Davies KA.
    Rheumatology (Oxford); 2004 May 03; 43(5):547-54. PubMed ID: 14747618
    [Abstract] [Full Text] [Related]

  • 7. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
    Cieślik P, Hrycek A.
    Autoimmunity; 2015 Jun 03; 48(4):242-50. PubMed ID: 25401491
    [Abstract] [Full Text] [Related]

  • 8. Soluble adhesion molecules in pediatric rheumatic diseases.
    Bloom BJ, Miller LC, Blier PR.
    J Rheumatol; 2002 Apr 03; 29(4):832-6. PubMed ID: 11950029
    [Abstract] [Full Text] [Related]

  • 9. Circulating endothelial cells as a marker of vascular dysfunction in patients with systemic lupus erythematosus by real-time polymerase chain reaction.
    Attia FM, Maaty A, Kalil FA.
    Arch Pathol Lab Med; 2011 Nov 03; 135(11):1482-5. PubMed ID: 22032577
    [Abstract] [Full Text] [Related]

  • 10. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
    Heshmat NM, El-Kerdany TH.
    Pediatr Allergy Immunol; 2007 Jun 03; 18(4):346-53. PubMed ID: 17346298
    [Abstract] [Full Text] [Related]

  • 11. Elevated Layilin-Positive Monocyte Levels in the Peripheral Blood of Patients with Systemic Lupus Erythematosus Reflect Their Autoimmune Status.
    Liu C, Wang Y, Zhang YH, Yuan Z, Zhang Z, Zeng X, Guan Z, Bahabayi A, Lu S.
    Immunol Invest; 2023 Nov 03; 52(7):879-896. PubMed ID: 37642473
    [Abstract] [Full Text] [Related]

  • 12. Vasculopathy and vasculitis in systemic lupus erythematosus.
    Cieślik P, Hrycek A, Kłuciński P.
    Pol Arch Med Wewn; 2008 Nov 03; 118(1-2):57-63. PubMed ID: 18405174
    [Abstract] [Full Text] [Related]

  • 13. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
    Amoura Z, Combadiere C, Faure S, Parizot C, Miyara M, Raphaël D, Ghillani P, Debre P, Piette JC, Gorochov G.
    Arthritis Rheum; 2003 Dec 03; 48(12):3487-96. PubMed ID: 14673999
    [Abstract] [Full Text] [Related]

  • 14. The Tie2 receptor antagonist angiopoietin-2 in systemic lupus erythematosus: its correlation with various disease activity parameters.
    Salama MK, Taha FM, Safwat M, Darweesh HE, Basel ME.
    Immunol Invest; 2012 Dec 03; 41(8):864-75. PubMed ID: 22989097
    [Abstract] [Full Text] [Related]

  • 15. Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus.
    Robak E, Kierstan M, Cebula B, Krawczynska A, Sysa-Jedrzejowska A, Wierzbowska A, Smolewski P, Robak T.
    Lupus; 2009 Apr 03; 18(4):332-41. PubMed ID: 19276301
    [Abstract] [Full Text] [Related]

  • 16. Circulating activated endothelial cells in systemic lupus erythematosus: further evidence for diffuse vasculopathy.
    Clancy R, Marder G, Martin V, Belmont HM, Abramson SB, Buyon J.
    Arthritis Rheum; 2001 May 03; 44(5):1203-8. PubMed ID: 11352255
    [Abstract] [Full Text] [Related]

  • 17. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA, El-Gendi HI, Ahmed HH.
    Clin Biochem; 2005 Feb 03; 38(2):134-41. PubMed ID: 15642275
    [Abstract] [Full Text] [Related]

  • 18. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Dolff S, Wilde B, Patschan S, Dürig J, Specker C, Philipp T, Kribben A, Witzke O.
    Scand J Immunol; 2007 Nov 03; 66(5):584-90. PubMed ID: 17868260
    [Abstract] [Full Text] [Related]

  • 19. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M.
    Arthritis Rheum; 2005 Jun 03; 52(6):1670-5. PubMed ID: 15934075
    [Abstract] [Full Text] [Related]

  • 20. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
    Du Y, Wu X, Chen M, Wang W, Xv W, Ye L, Wu D, Xue J, Sun W, Luo J, Wu H.
    Clin Exp Immunol; 2017 May 03; 188(2):234-242. PubMed ID: 28063160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.